Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07648095 · ClinicalTrials.gov registry record
Lacrifill for Ocular Surface Optimization in Cataract Surgery
A clinical trial, sponsored by The Eye Institute of West Florida.
- Not yet
- Registry status
- 65
- Enrollment target
NCT07648095 is a clinical trial that has not yet begun recruiting, run by The Eye Institute of West Florida. The registered enrollment target is 65 participants.
The verdict
NCT07648095 has not yet begun recruiting, sponsored by The Eye Institute of West Florida.
- NOT YET RECRUITING
- Registry status
- 65 participants
- Enrollment target
Study Summary
This is a single-site observational study designed to evaluate the efficacy of Lacrifill™ canalicular filler in optimizing ocular surface parameters and biometric precision in prospective cataract surgery patients with dry eye disease (DED).
Interventions
- DEVICE Lacrifill Canalicular Filler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2026-07-15 |
| Est. Completion | 2027-07-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07648095
The ClinicalTrials.gov registry entry for NCT07648095 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Eye Institute of West Florida, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lacrifill Canalicular Filler is the first listed.
NCT07648095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07648095 about?
NCT07648095 is a clinical study titled "Lacrifill for Ocular Surface Optimization in Cataract Surgery". This is a single-site observational study designed to evaluate the efficacy of Lacrifill™ canalicular filler in optimizing ocular surface parameters and biometric precision in prospective cataract surgery patients with dry eye disease (DED).
What is the current status of trial NCT07648095?
This trial is currently not yet recruiting. The enrollment target is 65 participants. The study started on 2026-07-15. Estimated completion is 2027-07-15.
What interventions are being tested in trial NCT07648095?
The interventions under investigation include: Lacrifill Canalicular Filler (DEVICE).
Who is sponsoring clinical trial NCT07648095?
This trial is sponsored by The Eye Institute of West Florida, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.